FİLİZ MERCAN SARIDAŞ

Dr. FİLİZ MERCAN SARIDAŞ

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Turkish Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
FSFİLİZ MERCAN SARIDAŞ
FİLİZ MERCAN SARIDAŞ
TTTugce Zor Turna
Tugce Zor Turna
EAEnsar Aydemir
Ensar Aydemir
CACoşkun ATEŞ
Coşkun ATEŞ
EHErhan Hocaoglu
Erhan Hocaoglu
CECANAN ERSOY
CANAN ERSOY
Background: Therapeutic plasma exchange (TPE) is a treatment method that can be used to provide euthyroidism before permanent treatment in patients with severe thyrotoxicosis, in cases of thyroid storm and in cases where antithyroid drug (ATD) cannot be used due to side effects or ineffectiveness. This study presented our results and experience on TPE in thyrotoxic patients. Material and Methods: The data of 10 patients who underwent plasmapheresis for thyrotoxicosis in Bursa Uludag University Faculty of Medicine Endocrinology Clinic were retrospectively analyzed and compared with the literature. Results: Ten patients, 6 female and 4 male, were included. The cause of hyperthyroidism was Graves’ disease in 8 patients and toxic multinodular goiter (TMNG) in 2 patients. It was observed that the reason for applying plasmapheresis in the patients was primarily due to toxic hepatitis. The mean number of plasmapheresis required to maintain euthyroidism was 4 (1-8). While no difference was found between the thyroid-stimulating hormone (TSH) results before and after TPE, free T4 (fT4) and free T3 (fT3) values were statistically significantly lower after TPE. It was observed that the leukocytes were considerably higher after TPE and the sodium and calcium values were markedly lower after TPE in the patients. After TPE, 7 patients underwent total thyroidectomy, 1 patient received radioactive iodine (RAI) treatment, and 2 were discharged with ATD treatment. Conclusions: TPE is an effective and safe treatment option that can be applied in cases where it is necessary to provide rapid euthyroidism before permanent treatments or non-thyroid surgical procedures or to treat life-threatening thyrotoxicosis. It requires experience in application and follow-up and provides rapid euthyroidism when performed in experienced centres.

1 April 2022 in Turkish Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
EAEnsar Aydemir
Ensar Aydemir
CACoşkun ATEŞ
Coşkun ATEŞ
FSFİLİZ MERCAN SARIDAŞ
FİLİZ MERCAN SARIDAŞ
EHErhan Hocaoglu
Erhan Hocaoglu
SCSoner Cander
Soner Cander
CECANAN ERSOY
CANAN ERSOY
Introduction Insulinomas constituting the most common cause of endogenous hyperinsulinism-related hypoglycemia are neuroendocrine tumors originating from pancreatic beta cells. They are generally benign and solitary lesions. Although most cases are sporadic, multiple endocrine neoplasia (MEN) 1-related patients are also present. Material and Method Thirteen patients followed up in Bursa Uludağ University Medical Faculty Endocrinology and Metabolic diseases clinic between the years 2012 and 2021 were retrospectively evaluated. Demographical, clinical, biochemical, radiological and histopathological data of the patients were assessed. Results Eight of the patients were females, and five were males with an average age of 43±14.9 years. Ten of the patients had sporadic, and three had MEN1 syndrome-related insulinoma. During the prolonged fasting test, the patients had a mean lowest plasma glucose level of 36.4 ± 6.2 mg/dl with a simultaneous mean insulin level of 11.3 (4.4 - 214.1) mIU/L and c-peptide level of 2.8 (0.46-12.8) mcg/L. In preoperative localization studies, a lesion was detected in 11 out of 13 (84.6%) patients with upper abdominal computed tomography (CT) and 6 out of 10 patients (60%) with magnetic resonance imaging (MRI). Six patients had grade 1, and 7 patients had grade 2 neuroendocrine tumor. The whole group's mean lesion diameter was 15 (11-48) mm. The mean patient follow-up duration was 30.5 ± 23 months. Hypoglycemia recurred in none of the patients in the postoperative period, and only two patients (15.4%) developed postoperative diabetes mellitus (DM). Conclusion Preoperative localization rates in insulinomas increased due to non-invasive imaging methods and technological developments in recent years. This will probably cause earlier diagnosis and treatment, and pancreas preserving surgery option will be more available in most insulinoma cases.

16 February 2026 in Archives of Osteoporosis
Verified
Journal Article
Open access
PDF file
OGOzen Oz Öz Gul
Ozen Oz Öz Gul
ZCZeynep Cantürk
Zeynep Cantürk
SOSaadettin Ozturk
Saadettin Ozturk
NONilufer Ozdemir
Nilufer Ozdemir
DCDilek Kılınç Candemir
Dilek Kılınç Candemir
GOGuven Ozkaya
Guven Ozkaya
Summary: We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations. Background: Diabetes mellitus (DM) is a recognized risk factor for bone fragility. While type 1 DM (T1DM) is typically associated with low bone mineral density (BMD), type 2 DM (T2DM) often presents with higher BMD despite increased fracture risk. Large-scale comparative studies remain limited. Objective: To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM. Methods: This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD. Results: Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis. Conclusion: This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.

30 September 2025 in Acta Paediatrica
Verified
Journal Article
Closed access
EHErhan Hocaoglu
Erhan Hocaoglu
HNHatice Nursoy
Hatice Nursoy
FSFİLİZ MERCAN SARIDAŞ
FİLİZ MERCAN SARIDAŞ
MYMuge Yasar
Muge Yasar
KKKadircan Karatoprak
Kadircan Karatoprak
SCSoner Cander
Soner Cander

11 February 2025 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
FSFurkan Sarıdaş
Furkan Sarıdaş
FSFİLİZ MERCAN SARIDAŞ
FİLİZ MERCAN SARIDAŞ
EKEmine Rabia Koç
Emine Rabia Koç
CSCander Soner
Cander Soner
TFTuran Omer Faruk
Turan Omer Faruk

1 April 2022 in Turkish Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
CACoşkun ATEŞ
Coşkun ATEŞ
GAGül Ada
Gül Ada
FSFİLİZ MERCAN SARIDAŞ
FİLİZ MERCAN SARIDAŞ
EAEnsar Aydemir
Ensar Aydemir
EHErhan Hocaoglu
Erhan Hocaoglu
EEErdinç Ertürk
Erdinç Ertürk
Background: Primary hyperaldosteronism (PHA) is a primarily treatable cause of arterial hypertension characterized by low plasma renin and high aldosterone levels. The prevalence of secondary hypertension as a common endocrine cause is 5-13%. The plasma aldosterone/renin ratio (ARR) is the best available method for PHA screening. One or more confirmatory tests may be required to confirm or exclude patients' diagnoses. One frequently used confirmatory test is the saline infusion test (SİT). We aimed to screen the patients who underwent SİT with the preliminary diagnosis of PHA and to compare the results of the patients diagnosed with essential hypertension (EH) and PHA. Material and Methods: Seventy-seven patients with a history of drug-resistant hypertension or unexplained spontaneous or diuretic-induced hypokalemia or adrenal incidentaloma, or a family history of early-onset hypertension or cerebrovascular accident at a young age (0.05). Basal plasma aldosterone (p